NOTICE OF ALLOWANCE - ISSUED
issued
on 04 Jun 2024
Last Applicant/ Owned by
450 Water Street
Cambridge
MA
02141
Serial Number
98002517 filed on 18th May 2023
Registration Number
N/A
Correspondent Address
Karen Lim
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
KYNLUVON
Pharmaceutical products for the prevention and treatment of immunological diseases; pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer's
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical products for the prevention and treatment of immunological diseases; pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer's
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98002517
Mark Type
No Service/Collective Mark
Attorney Docket Number
No GENZ 2306601
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Jun 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 02th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 02th Apr 2024 | PUBLISHED FOR OPPOSITION |
| 13th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 23rd Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 23rd Feb 2024 | EXAMINER'S AMENDMENT ENTERED |
| 23rd Feb 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 23rd Feb 2024 | EXAMINERS AMENDMENT E-MAILED |
| 23rd Feb 2024 | EXAMINERS AMENDMENT -WRITTEN |
| 12th Feb 2024 | ASSIGNED TO EXAMINER |